Franklin Resources »

Inhibrx Biosciences shares owned by Franklin Resources

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Franklin Resources from 13F filings

Historical chart of Franklin Resources investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Franklin Resources consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Franklin Resources

Quarter filed Position value Share count Share price at filing
2024-06-30 $320k 23k 14.19

More positions owned by Franklin Resources

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Bank of America Corporation (BAC)
Broadcom (AVGO)

View all positions for Franklin Resources

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences